Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
DAB389
dabrafenib Lung Cancer Malignant Melanoma Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Dabrafenib Lymphoma Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
dacarbazine Dacogen Malignant Melanoma Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Dacarbazine Lymphoma Soft Tissue Sarcomas Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
dacomitinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Dacomitinib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
dactinomycin Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Soft Tissue Sarcomas Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Testicular Cancer
dactinomycin-D
daratumumab Multiple Myeloma Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Daratumumab Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
daratumumab and hyaluronidase Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
darvalumab
Darzalex faspro
dasatinib Leukemia Dasatinib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
Daunomycin
daunorubicin Leukemia Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Daunorubicin Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
daunorubicin and cytarabine liposome Daunorubicin and Cytarabine Liposome Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
daunorubicin liposome Kaposi's Sarcoma Daunorubicin Liposome
Daurismo
DCF
decitabine Leukemia Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Decitabine Myelodysplastic Syndrome Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
decitabine/cedazuridine Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
degarelix Degarelix Prostate Cancer
denileukin diftitox
dexamethasone Colorectal Cancer Leukemia Lymphoma Multiple Myeloma Prostate Cancer Common Regimens for Chemotherapy-Induced Nausea and Vomiting Lung Cancer Malignant Mesothelioma Ovarian Cancer (Epithelial) Waldenström's Macroglobulinemia
DH
Diaminocyclohexane platinum
DIC Dacarbazine Dabrafenib
dolasetron
dostarlimab-gxly
Doxil Lymphoma Doxorubicin liposome
doxorubicin liposome Doxorubicin liposome Kaposi's Sarcoma Ovarian Cancer (Epithelial) Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Breast Cancer Endometrial Cancer Multiple Myeloma Soft Tissue Sarcomas Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
dronabinol Common Regimens for Chemotherapy-Induced Nausea and Vomiting Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting: